Publications by authors named "S S Jeffrey"

Objective: Timely access to data is needed to improve care for substance-exposed birthing persons and their infants, a significant public health problem in the United States. We examined the current state of birthing person and infant/child (dyad) data-sharing capabilities supported by health information exchange (HIE) standards and HIE network capabilities for data exchange to inform point-of-care needs assessment for the substance-exposed dyad.

Material And Methods: A cross-map analysis was performed using a set of dyadic data elements focused on pediatric development and longitudinal supportive care for substance-exposed dyads (70 birthing person and 110 infant/child elements).

View Article and Find Full Text PDF

Introduction: Children with Attention Deficit/Hyperactivity Disorder (ADHD) participated in a randomized clinical trial comparing animal-assisted intervention (AAI) to psychosocial treatment as usual (TAU). This brief report describes effects of AAI on acute HPA axis reactivity and regulation. Saliva was collected before, during, and after psychosocial intervention sessions with and without therapy dogs and later assayed for cortisol (ug/dL).

View Article and Find Full Text PDF

Transgender and gender diverse people presumed female at birth experience gynaecological conditions, such as chronic pelvic pain at elevated rates, estimated to impact between 51% and 72% of this population, compared to rates of up to 26.6% in cisgender women. The negative impact of these conditions is likely amplified due to limited access to safe and affirming healthcare.

View Article and Find Full Text PDF

Y-box binding protein-1 (YB-1) is a proto-oncogenic protein associated with protein translation regulation. It plays a crucial role in the development and progression of triple-negative breast cancer (TNBC). In this study, we describe a promising approach to inhibit YB-1 using SU056, a small-molecule inhibitor.

View Article and Find Full Text PDF
Article Synopsis
  • Gonorrhea is a major public health issue in Canada, being the second most common bacterial STI, and the Gonococcal Antimicrobial Surveillance Programme has been tracking its antimicrobial resistance since 1985.
  • In 2021, Canada saw a 9.9% increase in gonococcal cultures submitted, revealing growing resistance to cefixime and identifying one ceftriaxone-resistant isolate, despite no significant changes in ceftriaxone resistance overall.
  • The monitoring highlights a significant public health threat due to rising antimicrobial resistance, underscoring the necessity for ongoing surveillance to inform effective treatment options.*
View Article and Find Full Text PDF